Pular para o conteúdo
· Preenchimentos dérmicos
SKU 11119

Revanesse Versa™+

Em stock
Volume
2 x 1,2 mL
Laboratório
Prollenium Medical Technologies Inc.
Origem
Canadá
Indicação
Facial line smoothing and volume enhancement
O preço profissional e o histórico são exclusivos de contas verificadas
allpara fornece profissionais licenciados. Inicie sessão ou peça uma conta B2B para ver os preços em tempo real, os escalões por volume e o histórico de preços.

Revanesse Versa™+ is a hyaluronic acid injectable by Prollenium Medical Technologies, developed to correct facial wrinkles and folds that are moderate to severe. Qualified medical professionals use it in adults aged 22 years and older to treat facial wrinkles and folds, for example nasolabial folds. The product contains 25 mg/mL of cross-linked hyaluronic acid with 0.3% lidocaine and is intended for professional use. It comes in pre-filled syringes, including a 1.2 mL configuration, and is FDA approved in the United States.

*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.

Principais vantagens de Revanesse Versa™+

  • Bioresorbable cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
  • Indicated for moderate to severe facial wrinkles and folds, such as nasolabial folds
  • Placed in the mid to deep dermis
  • FDA approved for the cosmetic treatment of facial wrinkles and creases
  • Supported by a randomised, multicentre, double-blind split-face study of 100 patients
  • Delivered in pre-filled disposable glass syringes, two 1.2 mL per box with two sterile needles
Informação essencial
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origem Canada
Certificação FDA approved
Composição Bioresorbable cross-linked hyaluronic acid 25 mg/mL containing 0.3% lidocaine
Volume / Tamanho 1.2 ml
Embalagem 2 pre-filled disposable glass syringes x 1.2 mL, with two sterile needles
Tipo de utilização Professional use only - injectable dermal filler for facial wrinkle smoothing, in patients 22 years of age and older
Profundidade de injeção Mid to deep dermis. Intended for intradermal use only and must not be injected into blood vessels.

Indicações e utilização profissional

Principais indicações

  • Correction of moderate to severe facial wrinkles and folds
  • Nasolabial folds

Utilização profissional

For professional use. Revanesse Versa+ is injected by qualified, trained doctors into the dermis of the patient, and is not for retail sale or self-administration. It is intended for intradermal use only and must not be injected into blood vessels: unintentional intravascular injection is rare but its complications can be serious and may be permanent, including vision abnormalities, blindness, stroke, temporary scabs and permanent scarring of the skin. Stop immediately and seek specialist assessment if the patient shows changes in vision, signs of a stroke, white appearance of the skin, or unusual pain during or shortly after treatment. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing, and confirm the box seal is unbroken and the product in date before use.

Zonas de tratamento

  • Face
  • Nasolabial folds

Perfil do paciente

Indicated for adults 22 years of age or more seeking correction of moderate to severe facial wrinkles and folds. It should not be used in patients who are pregnant or breastfeeding, as safety in these groups has not been studied; who have a history of hypertrophic scarring or keloid formation; who have evidence of scars at the intended treatment sites; who have acne or other inflammatory skin diseases such as rosacea, seborrhoeic dermatitis or psoriasis; or who have an allergic history including severe allergic reactions, atopy, allergy to hyaluronic acid products, or allergy to streptococcal proteins. Treatment should also be deferred where there is an active inflammatory process such as pimples, hives, rashes or cysts, until it has resolved.

Como funciona Revanesse Versa™+ ​

Versa+ is injected into the dermis using a variety of techniques, placing a small portion of the gel beneath a crease or wrinkle in the skin; the augmentation of the tissue produces a smoothing effect at the surface. The hyaluronic acid is a naturally occurring substance produced by bacteria and purified for use as an injectable soft tissue filler. Because the gel is bioresorbable, the correction is temporary rather than permanent. The 0.3% lidocaine is present for injection comfort.

Porquê encomendar na Allpara

A Allpara oferece produtos REVANESSE originais e verificados de fornecedores selecionados, com rastreabilidade total dos lotes e apoio especializado. Servimos clínicas e profissionais de estética com produtos com certificação CE, entrega rápida em toda a UE a partir do nosso armazém na UE e preços profissionais competitivos. A nossa prioridade é a segurança, a satisfação e os resultados dos seus pacientes, com apoio pós-venda dedicado para a sua tranquilidade.

Perguntas frequentes

What clinical evidence supports Revanesse Versa+?

A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.

Is Versa+ FDA approved?

Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.

Mais de Prollenium Medical Technologies

Ver laboratório

Alternativas para a clínica

Todos os produtos

Revanesse Versa™+

Em stock
Marcação CE Revanesse Versa™+
Preços exclusivos para contas verificadas
Inicie sessão ou peça uma conta B2B para ver o seu preço.
Pedir conta B2B

Revanesse Versa™+ is a hyaluronic acid injectable by Prollenium Medical Technologies, developed to correct facial wrinkles and folds that are moderate to severe. Qualified medical professionals use it in adults aged 22 years and older to treat facial wrinkles and folds, for example nasolabial folds. The product contains 25 mg/mL of cross-linked hyaluronic acid with 0.3% lidocaine and is intended for professional use. It comes in pre-filled syringes, including a 1.2 mL configuration, and is FDA approved in the United States.

*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.

Principais vantagens de Revanesse Versa™+

  • Bioresorbable cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
  • Indicated for moderate to severe facial wrinkles and folds, such as nasolabial folds
  • Placed in the mid to deep dermis
  • FDA approved for the cosmetic treatment of facial wrinkles and creases
  • Supported by a randomised, multicentre, double-blind split-face study of 100 patients
  • Delivered in pre-filled disposable glass syringes, two 1.2 mL per box with two sterile needles
Informação essencial
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origem Canada
Certificação FDA approved
Composição Bioresorbable cross-linked hyaluronic acid 25 mg/mL containing 0.3% lidocaine
Volume / Tamanho 1.2 ml
Embalagem 2 pre-filled disposable glass syringes x 1.2 mL, with two sterile needles
Tipo de utilização Professional use only - injectable dermal filler for facial wrinkle smoothing, in patients 22 years of age and older
Profundidade de injeção Mid to deep dermis. Intended for intradermal use only and must not be injected into blood vessels.

Indicações e utilização profissional

Principais indicações

  • Correction of moderate to severe facial wrinkles and folds
  • Nasolabial folds

Utilização profissional

For professional use. Revanesse Versa+ is injected by qualified, trained doctors into the dermis of the patient, and is not for retail sale or self-administration. It is intended for intradermal use only and must not be injected into blood vessels: unintentional intravascular injection is rare but its complications can be serious and may be permanent, including vision abnormalities, blindness, stroke, temporary scabs and permanent scarring of the skin. Stop immediately and seek specialist assessment if the patient shows changes in vision, signs of a stroke, white appearance of the skin, or unusual pain during or shortly after treatment. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing, and confirm the box seal is unbroken and the product in date before use.

Zonas de tratamento

  • Face
  • Nasolabial folds

Perfil do paciente

Indicated for adults 22 years of age or more seeking correction of moderate to severe facial wrinkles and folds. It should not be used in patients who are pregnant or breastfeeding, as safety in these groups has not been studied; who have a history of hypertrophic scarring or keloid formation; who have evidence of scars at the intended treatment sites; who have acne or other inflammatory skin diseases such as rosacea, seborrhoeic dermatitis or psoriasis; or who have an allergic history including severe allergic reactions, atopy, allergy to hyaluronic acid products, or allergy to streptococcal proteins. Treatment should also be deferred where there is an active inflammatory process such as pimples, hives, rashes or cysts, until it has resolved.

Como funciona Revanesse Versa™+ ​

Versa+ is injected into the dermis using a variety of techniques, placing a small portion of the gel beneath a crease or wrinkle in the skin; the augmentation of the tissue produces a smoothing effect at the surface. The hyaluronic acid is a naturally occurring substance produced by bacteria and purified for use as an injectable soft tissue filler. Because the gel is bioresorbable, the correction is temporary rather than permanent. The 0.3% lidocaine is present for injection comfort.

Porquê encomendar na Allpara

A Allpara oferece produtos REVANESSE originais e verificados, com rastreabilidade total dos lotes, stock com certificação CE, entrega rápida em toda a UE e apoio pós-venda especializado.

Perguntas frequentes

What clinical evidence supports Revanesse Versa+?

A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.

Is Versa+ FDA approved?

Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.

Mais de Prollenium Medical Technologies

Ver o laboratório →
* Produto de uso profissional. A embalagem pode variar consoante o lote ou o mercado. Consulte as instruções de utilização fornecidas para as indicações completas e as contraindicações.